Ciprian Catana, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 90 | 2024 | 6547 | 6.600 |
Why?
|
Magnetic Resonance Imaging | 79 | 2024 | 36532 | 2.500 |
Why?
|
Image Processing, Computer-Assisted | 30 | 2022 | 8923 | 2.040 |
Why?
|
Whole Body Imaging | 9 | 2022 | 281 | 1.800 |
Why?
|
Dopamine | 5 | 2022 | 1582 | 1.040 |
Why?
|
Fluorodeoxyglucose F18 | 18 | 2024 | 2024 | 1.030 |
Why?
|
Brain | 35 | 2024 | 27171 | 0.950 |
Why?
|
Movement | 4 | 2018 | 1462 | 0.940 |
Why?
|
Collagen Type I | 4 | 2024 | 615 | 0.890 |
Why?
|
Receptors, GABA | 10 | 2024 | 312 | 0.860 |
Why?
|
Abdomen | 4 | 2018 | 1134 | 0.810 |
Why?
|
Phantoms, Imaging | 14 | 2023 | 2475 | 0.730 |
Why?
|
Molecular Imaging | 5 | 2023 | 822 | 0.690 |
Why?
|
Radiopharmaceuticals | 16 | 2024 | 2699 | 0.660 |
Why?
|
Fibrin | 7 | 2024 | 513 | 0.610 |
Why?
|
Systems Integration | 3 | 2016 | 427 | 0.610 |
Why?
|
Respiratory-Gated Imaging Techniques | 1 | 2018 | 73 | 0.580 |
Why?
|
Tomography, X-Ray Computed | 14 | 2024 | 20659 | 0.570 |
Why?
|
Abdominal Neoplasms | 1 | 2018 | 284 | 0.540 |
Why?
|
Equipment Design | 6 | 2019 | 3481 | 0.530 |
Why?
|
Artifacts | 7 | 2020 | 1893 | 0.510 |
Why?
|
Gallium Radioisotopes | 5 | 2024 | 195 | 0.500 |
Why?
|
Receptors, Dopamine D1 | 1 | 2016 | 276 | 0.470 |
Why?
|
Algorithms | 18 | 2022 | 14071 | 0.460 |
Why?
|
Respiration | 3 | 2018 | 1653 | 0.440 |
Why?
|
Neuroglia | 5 | 2018 | 964 | 0.440 |
Why?
|
Nuclear Medicine | 3 | 2023 | 261 | 0.430 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2019 | 518 | 0.430 |
Why?
|
Receptors, Dopamine D2 | 5 | 2022 | 471 | 0.420 |
Why?
|
Metals | 1 | 2017 | 710 | 0.400 |
Why?
|
Acoustics | 1 | 2013 | 235 | 0.380 |
Why?
|
Head | 2 | 2019 | 925 | 0.380 |
Why?
|
Glioblastoma | 5 | 2019 | 3459 | 0.360 |
Why?
|
Raclopride | 5 | 2022 | 98 | 0.340 |
Why?
|
Image Enhancement | 4 | 2017 | 2858 | 0.340 |
Why?
|
Prostheses and Implants | 1 | 2017 | 1273 | 0.340 |
Why?
|
Memory, Short-Term | 1 | 2016 | 1003 | 0.330 |
Why?
|
Motion | 4 | 2019 | 781 | 0.330 |
Why?
|
Contrast Media | 7 | 2019 | 5329 | 0.320 |
Why?
|
Copper Radioisotopes | 3 | 2024 | 99 | 0.290 |
Why?
|
Humans | 90 | 2024 | 765968 | 0.290 |
Why?
|
Corpus Striatum | 3 | 2022 | 1218 | 0.280 |
Why?
|
Nerve Net | 2 | 2016 | 2309 | 0.270 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2006 | 139 | 0.260 |
Why?
|
Brain Mapping | 9 | 2018 | 6601 | 0.260 |
Why?
|
Dementia | 2 | 2018 | 2744 | 0.260 |
Why?
|
Receptors, Dopamine D3 | 3 | 2017 | 106 | 0.260 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 3 | 2019 | 1643 | 0.250 |
Why?
|
Transducers | 1 | 2006 | 239 | 0.240 |
Why?
|
Diffusion Magnetic Resonance Imaging | 5 | 2022 | 2798 | 0.240 |
Why?
|
Neurology | 1 | 2012 | 785 | 0.230 |
Why?
|
Cerebral Cortex | 3 | 2024 | 5767 | 0.220 |
Why?
|
Subtraction Technique | 1 | 2006 | 512 | 0.220 |
Why?
|
Meninges | 1 | 2024 | 200 | 0.200 |
Why?
|
Acetamides | 3 | 2024 | 260 | 0.190 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2018 | 1484 | 0.190 |
Why?
|
BCG Vaccine | 1 | 2024 | 380 | 0.190 |
Why?
|
Reproducibility of Results | 11 | 2022 | 20124 | 0.180 |
Why?
|
Male | 49 | 2024 | 363698 | 0.180 |
Why?
|
Intracranial Thrombosis | 1 | 2021 | 109 | 0.180 |
Why?
|
Adult | 31 | 2024 | 223044 | 0.170 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2017 | 1083 | 0.160 |
Why?
|
Monte Carlo Method | 2 | 2016 | 1238 | 0.160 |
Why?
|
Echo-Planar Imaging | 2 | 2022 | 648 | 0.160 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 2 | 2024 | 253 | 0.160 |
Why?
|
Lung Injury | 1 | 2023 | 430 | 0.160 |
Why?
|
Thrombosis | 4 | 2021 | 2949 | 0.150 |
Why?
|
Nucleus Accumbens | 2 | 2022 | 360 | 0.150 |
Why?
|
Yttrium Radioisotopes | 1 | 2019 | 116 | 0.150 |
Why?
|
Chicago | 1 | 2019 | 255 | 0.150 |
Why?
|
Sensitivity and Specificity | 7 | 2021 | 14652 | 0.150 |
Why?
|
Spleen | 1 | 2024 | 2296 | 0.150 |
Why?
|
Papio | 2 | 2017 | 671 | 0.150 |
Why?
|
Thalamus | 2 | 2014 | 1048 | 0.150 |
Why?
|
Serotonin 5-HT1 Receptor Antagonists | 1 | 2017 | 9 | 0.150 |
Why?
|
Middle Aged | 29 | 2024 | 223009 | 0.150 |
Why?
|
Stilbenes | 1 | 2018 | 154 | 0.150 |
Why?
|
Drug Partial Agonism | 1 | 2017 | 24 | 0.150 |
Why?
|
Capillary Permeability | 2 | 2019 | 768 | 0.140 |
Why?
|
Atrial Appendage | 1 | 2021 | 284 | 0.140 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2017 | 42 | 0.140 |
Why?
|
Female | 41 | 2024 | 396112 | 0.140 |
Why?
|
Neuroendocrine Tumors | 1 | 2024 | 654 | 0.140 |
Why?
|
Skull | 3 | 2019 | 811 | 0.140 |
Why?
|
Normal Distribution | 1 | 2018 | 267 | 0.140 |
Why?
|
Models, Biological | 1 | 2013 | 9443 | 0.140 |
Why?
|
Motor Neuron Disease | 1 | 2017 | 98 | 0.140 |
Why?
|
Head Movements | 1 | 2018 | 149 | 0.140 |
Why?
|
Pelvis | 1 | 2021 | 738 | 0.130 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2021 | 3672 | 0.130 |
Why?
|
Gadolinium | 2 | 2019 | 965 | 0.130 |
Why?
|
Heart | 2 | 2020 | 4414 | 0.130 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2024 | 550 | 0.130 |
Why?
|
Radiation Injuries | 1 | 2023 | 1181 | 0.130 |
Why?
|
Brain Neoplasms | 4 | 2019 | 9071 | 0.130 |
Why?
|
Quinpirole | 1 | 2015 | 27 | 0.130 |
Why?
|
Aged | 22 | 2024 | 171117 | 0.130 |
Why?
|
Dopamine Agonists | 2 | 2015 | 346 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2019 | 276 | 0.120 |
Why?
|
Venous Thrombosis | 2 | 2015 | 1327 | 0.120 |
Why?
|
Blood Glucose | 2 | 2024 | 6424 | 0.120 |
Why?
|
Animals | 27 | 2024 | 168764 | 0.120 |
Why?
|
Starvation | 1 | 2015 | 141 | 0.120 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2022 | 1094 | 0.120 |
Why?
|
Hip | 1 | 2016 | 249 | 0.120 |
Why?
|
Photons | 2 | 2016 | 572 | 0.120 |
Why?
|
Radiometry | 2 | 2022 | 804 | 0.120 |
Why?
|
Stomach Neoplasms | 1 | 2024 | 1471 | 0.110 |
Why?
|
Medical Oncology | 2 | 2019 | 2339 | 0.110 |
Why?
|
Workflow | 1 | 2019 | 862 | 0.110 |
Why?
|
Cholangiocarcinoma | 1 | 2019 | 578 | 0.110 |
Why?
|
Bile Duct Neoplasms | 1 | 2019 | 626 | 0.110 |
Why?
|
Object Attachment | 1 | 2017 | 329 | 0.110 |
Why?
|
Fibromyalgia | 1 | 2018 | 406 | 0.110 |
Why?
|
Placebo Effect | 1 | 2017 | 514 | 0.110 |
Why?
|
Low Back Pain | 1 | 2022 | 987 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2017 | 3356 | 0.110 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2024 | 1758 | 0.110 |
Why?
|
Aniline Compounds | 1 | 2018 | 1075 | 0.100 |
Why?
|
Analgesia | 1 | 2017 | 461 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7425 | 0.100 |
Why?
|
Signal Transduction | 1 | 2016 | 23601 | 0.100 |
Why?
|
Mother-Child Relations | 1 | 2017 | 499 | 0.100 |
Why?
|
Unconsciousness | 1 | 2014 | 250 | 0.100 |
Why?
|
Sensory Receptor Cells | 1 | 2017 | 513 | 0.100 |
Why?
|
Cardiovascular System | 1 | 2020 | 841 | 0.100 |
Why?
|
Bone and Bones | 2 | 2014 | 2554 | 0.100 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2018 | 784 | 0.100 |
Why?
|
Carbon Radioisotopes | 3 | 2018 | 543 | 0.090 |
Why?
|
Motor Neurons | 1 | 2016 | 869 | 0.090 |
Why?
|
Pyridines | 3 | 2024 | 2888 | 0.090 |
Why?
|
Models, Neurological | 3 | 2015 | 1747 | 0.090 |
Why?
|
Thermogenesis | 1 | 2015 | 496 | 0.090 |
Why?
|
Neoplasm Staging | 4 | 2019 | 11206 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 1 | 2021 | 1529 | 0.090 |
Why?
|
Pyrimidines | 3 | 2018 | 3047 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1087 | 0.080 |
Why?
|
Basal Ganglia | 1 | 2013 | 549 | 0.080 |
Why?
|
Cerebrovascular Circulation | 2 | 2017 | 2674 | 0.080 |
Why?
|
Fibroblast Growth Factors | 1 | 2015 | 871 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3446 | 0.080 |
Why?
|
Scattering, Radiation | 1 | 2011 | 482 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3928 | 0.080 |
Why?
|
Multiple Sclerosis | 1 | 2024 | 3213 | 0.080 |
Why?
|
Motor Cortex | 1 | 2016 | 1003 | 0.080 |
Why?
|
Young Adult | 10 | 2024 | 59889 | 0.080 |
Why?
|
Dopamine Antagonists | 3 | 2015 | 278 | 0.080 |
Why?
|
Aged, 80 and over | 5 | 2018 | 59489 | 0.080 |
Why?
|
Kinetics | 2 | 2013 | 6274 | 0.080 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2016 | 1376 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1308 | 0.080 |
Why?
|
Protons | 2 | 2018 | 1073 | 0.080 |
Why?
|
Hodgkin Disease | 1 | 2016 | 1383 | 0.080 |
Why?
|
Delirium | 1 | 2020 | 1707 | 0.080 |
Why?
|
Organ Size | 1 | 2013 | 2260 | 0.080 |
Why?
|
tau Proteins | 1 | 2019 | 2112 | 0.070 |
Why?
|
Oxygen | 1 | 2020 | 4241 | 0.070 |
Why?
|
Pair Bond | 1 | 2007 | 9 | 0.070 |
Why?
|
Bayes Theorem | 1 | 2016 | 2354 | 0.070 |
Why?
|
Macaca mulatta | 4 | 2017 | 2341 | 0.070 |
Why?
|
Diagnostic Errors | 1 | 2015 | 1275 | 0.070 |
Why?
|
Quinazolines | 2 | 2011 | 1364 | 0.070 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2011 | 660 | 0.070 |
Why?
|
Brain Concussion | 1 | 2019 | 1432 | 0.070 |
Why?
|
Time Factors | 5 | 2018 | 40065 | 0.070 |
Why?
|
Brain Injuries | 1 | 2019 | 2060 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5444 | 0.070 |
Why?
|
Prefrontal Cortex | 1 | 2017 | 2224 | 0.070 |
Why?
|
Reference Values | 1 | 2013 | 4908 | 0.060 |
Why?
|
Pilot Projects | 2 | 2024 | 8733 | 0.060 |
Why?
|
Visual Perception | 1 | 2014 | 1394 | 0.060 |
Why?
|
Receptors, Opioid | 2 | 2017 | 144 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4353 | 0.060 |
Why?
|
Mice | 10 | 2024 | 81819 | 0.060 |
Why?
|
Tissue Distribution | 2 | 2022 | 2266 | 0.060 |
Why?
|
Migraine Disorders | 1 | 2017 | 1732 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8703 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16721 | 0.060 |
Why?
|
Equipment Failure Analysis | 1 | 2006 | 834 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2019 | 22223 | 0.060 |
Why?
|
Neural Pathways | 1 | 2014 | 3085 | 0.050 |
Why?
|
Epilepsy | 1 | 2019 | 3320 | 0.050 |
Why?
|
Pain | 2 | 2018 | 5077 | 0.050 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2015 | 1145 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9373 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11868 | 0.050 |
Why?
|
Leucovorin | 1 | 2024 | 641 | 0.050 |
Why?
|
Feasibility Studies | 4 | 2019 | 5302 | 0.050 |
Why?
|
Radio Waves | 1 | 2023 | 246 | 0.050 |
Why?
|
Cell Line, Tumor | 4 | 2024 | 17075 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 263 | 0.050 |
Why?
|
Radiotherapy Dosage | 2 | 2019 | 2865 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2598 | 0.050 |
Why?
|
Adolescent | 5 | 2024 | 88835 | 0.050 |
Why?
|
Rabbits | 2 | 2021 | 4734 | 0.050 |
Why?
|
Breast Neoplasms | 3 | 2017 | 21056 | 0.040 |
Why?
|
Inflammation | 2 | 2020 | 10850 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2014 | 3967 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 6220 | 0.040 |
Why?
|
Fluorouracil | 1 | 2024 | 1648 | 0.040 |
Why?
|
Lung | 2 | 2023 | 10033 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2023 | 1978 | 0.040 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 94 | 0.040 |
Why?
|
Technology, Radiologic | 1 | 2019 | 158 | 0.040 |
Why?
|
Afghanistan | 1 | 2019 | 78 | 0.040 |
Why?
|
Aorta, Abdominal | 1 | 2021 | 596 | 0.040 |
Why?
|
Iraq | 1 | 2019 | 93 | 0.040 |
Why?
|
Air | 1 | 2019 | 181 | 0.040 |
Why?
|
Computer Security | 1 | 2020 | 261 | 0.040 |
Why?
|
Computers | 1 | 2020 | 588 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2013 | 1526 | 0.040 |
Why?
|
Mice, Nude | 1 | 2024 | 3618 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2018 | 11083 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT1B | 1 | 2017 | 36 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2013 | 4544 | 0.040 |
Why?
|
Rats | 4 | 2015 | 23707 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2021 | 929 | 0.040 |
Why?
|
Fibrosis | 1 | 2024 | 2070 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6942 | 0.030 |
Why?
|
Neoplasms | 2 | 2019 | 22340 | 0.030 |
Why?
|
Biomedical Research | 1 | 2012 | 3458 | 0.030 |
Why?
|
Aging | 1 | 2016 | 8731 | 0.030 |
Why?
|
Organometallic Compounds | 2 | 2010 | 644 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1125 | 0.030 |
Why?
|
Neuroimmunomodulation | 1 | 2018 | 186 | 0.030 |
Why?
|
Carbon Isotopes | 1 | 2017 | 451 | 0.030 |
Why?
|
Prochlorperazine | 1 | 2015 | 16 | 0.030 |
Why?
|
Spin Labels | 1 | 2017 | 334 | 0.030 |
Why?
|
Glioma | 1 | 2011 | 3493 | 0.030 |
Why?
|
Sodium Chloride | 1 | 2017 | 576 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15398 | 0.030 |
Why?
|
Collagen | 1 | 2023 | 2618 | 0.030 |
Why?
|
Behavior, Animal | 2 | 2017 | 1865 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2017 | 1377 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 856 | 0.030 |
Why?
|
Blast Injuries | 1 | 2019 | 318 | 0.030 |
Why?
|
Diprenorphine | 1 | 2014 | 13 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 629 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5696 | 0.030 |
Why?
|
Myocardium | 2 | 2022 | 4760 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10729 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2015 | 8102 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2022 | 81514 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2643 | 0.030 |
Why?
|
Pain Threshold | 1 | 2017 | 604 | 0.030 |
Why?
|
Computer Simulation | 2 | 2017 | 6255 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15652 | 0.030 |
Why?
|
Placebos | 1 | 2017 | 1659 | 0.030 |
Why?
|
Prognosis | 3 | 2019 | 29922 | 0.030 |
Why?
|
Oxytocin | 1 | 2017 | 404 | 0.030 |
Why?
|
Hypercapnia | 1 | 2014 | 259 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2017 | 1153 | 0.020 |
Why?
|
Benzamides | 1 | 2017 | 1377 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 366 | 0.020 |
Why?
|
Arterial Occlusive Diseases | 1 | 2015 | 729 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2395 | 0.020 |
Why?
|
Cohort Studies | 3 | 2018 | 41649 | 0.020 |
Why?
|
Astrocytes | 1 | 2018 | 1345 | 0.020 |
Why?
|
Dexmedetomidine | 1 | 2014 | 316 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2015 | 1628 | 0.020 |
Why?
|
Fluorine | 1 | 2010 | 76 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3202 | 0.020 |
Why?
|
Reward | 1 | 2017 | 981 | 0.020 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2010 | 68 | 0.020 |
Why?
|
Adiponectin | 1 | 2015 | 1119 | 0.020 |
Why?
|
Heterocyclic Compounds | 1 | 2010 | 245 | 0.020 |
Why?
|
Microglia | 1 | 2018 | 1372 | 0.020 |
Why?
|
Narcotic Antagonists | 1 | 2014 | 590 | 0.020 |
Why?
|
Software | 2 | 2016 | 4462 | 0.020 |
Why?
|
Military Personnel | 1 | 2019 | 1252 | 0.020 |
Why?
|
Fasting | 1 | 2015 | 1606 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1881 | 0.020 |
Why?
|
Extracellular Space | 1 | 2011 | 563 | 0.020 |
Why?
|
Diffusion | 1 | 2011 | 808 | 0.020 |
Why?
|
Consciousness | 1 | 2014 | 601 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1456 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2013 | 1884 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2242 | 0.020 |
Why?
|
Internet | 1 | 2020 | 3106 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2352 | 0.020 |
Why?
|
Pitheciidae | 1 | 2007 | 1 | 0.020 |
Why?
|
Models, Chemical | 1 | 2010 | 608 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1224 | 0.020 |
Why?
|
Indoles | 1 | 2015 | 1839 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3561 | 0.020 |
Why?
|
Glucose | 2 | 2010 | 4335 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2017 | 2593 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 26318 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2016 | 2410 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7123 | 0.020 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 412 | 0.020 |
Why?
|
Molecular Structure | 1 | 2010 | 1885 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2010 | 2477 | 0.020 |
Why?
|
Veterans | 1 | 2019 | 2664 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2015 | 3222 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 2 | 2008 | 4034 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18293 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2194 | 0.010 |
Why?
|
Models, Statistical | 1 | 2018 | 5089 | 0.010 |
Why?
|
Child | 1 | 2010 | 80564 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11022 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2011 | 2056 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 13024 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15880 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2007 | 1827 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2007 | 6203 | 0.010 |
Why?
|
Electroencephalography | 1 | 2014 | 6273 | 0.010 |
Why?
|
Peptides | 1 | 2010 | 4331 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3529 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 65188 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2008 | 2531 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39193 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 16047 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10429 | 0.010 |
Why?
|
Infant | 1 | 2017 | 36386 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12056 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 22332 | 0.010 |
Why?
|
Prospective Studies | 1 | 2007 | 54802 | 0.000 |
Why?
|